Literature DB >> 9769471

Human psoriatic skin in organ culture: comparison with normal skin exposed to exogenous growth factors and effects of an antibody to the EGF receptor.

J Varani1, S Kang, S Stoll, J T Elder.   

Abstract

Organ cultures were established from psoriatic lesional skin of 24 different individuals and maintained for 8 days under serum-free, growth-factor-free conditions. Nonlesional skin from 14 of the same individuals and normal skin from another 12 individuals were also maintained in organ culture. At the end of the incubation period, the tissues were fixed in formalin and examined histologically. Lesional skin continued to express features of psoriatic plaque, which included irregularly shaped epithelial cells arranged in a disorganized fashion, and elongation of the rete ridges with a thickening in their lower portion. Abnormal epidermal differentiation and separation of the upper epidermal layers from the lower layers was also a consistent feature. In contrast, nonlesional skin from psoriatic patients exhibited a histological appearance which resembled that of site-matched normal skin. When normal skin was exposed to a growth-factor-enriched culture medium during the 8-day incubation period, it exhibited a histological appearance similar to that of psoriatic skin. In addition to abnormal histological features, the psoriatic skin in organ culture released higher amounts of matrix metalloproteinase-9 (MMP-9; 92-kD gelatinase B/type IV collagenase) into the culture fluid than either nonlesional skin or normal skin. Organ cultures of psoriatic lesional skin from 6 individuals were maintained for 8 days in the presence of an antibody to the human epidermal growth-factor (EGF) receptor. The abnormal histological features of the psoriatic tissue were partially ameliorated in the presence of the antibody. These data suggest that growth factors which act through the EGF receptor help to maintain the psoriatic phenotype in organ culture. They also suggest that organ culture may provide a useful tool with which to elucidate the pathophysiological mechanisms of altered keratinocyte proliferation and differentiation in psoriasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769471     DOI: 10.1159/000028031

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  6 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

Review 2.  Recent advances on the roles of epidermal growth factor receptor in psoriasis.

Authors:  Sijia Wang; Zhuoli Zhang; Han Peng; Kang Zeng
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

3.  Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice.

Authors:  Narasimharao Bhagavathula; Kamalakar C Nerusu; Gary J Fisher; Gao Liu; Archana B Thakur; Lorraine Gemmell; Shankar Kumar; Zenghai H Xu; Paul Hinton; Naoya Tsurushita; Nicholas F Landolfi; John J Voorhees; James Varani
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner.

Authors:  Andrew Johnston; Johann E Gudjonsson; Abhishek Aphale; Andrew M Guzman; Stefan W Stoll; James T Elder
Journal:  J Invest Dermatol       Date:  2010-10-21       Impact factor: 8.551

Review 5.  Organoid culture to study epithelial cell differentiation and barrier formation in the colon: bridging the gap between monolayer cell culture and human subject research.

Authors:  James Varani; Shannon D McClintock; Muhammad Nadeem Aslam
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-01-05       Impact factor: 2.416

6.  Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin.

Authors:  J Varani; Y Hattori; Y Chi; T Schmidt; P Perone; M E Zeigler; D J Fader; T M Johnson
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.